16.05 2013 . 2,5 .
Visiongain, 2013 . () 2,44 . , Pharma Times. 20% , 2012 . , 2% .
2023 ., , , , .
, . 2012 . Celltrion Hospira (EMA) , 2014 .
, 2014 . . Rituxan (rituximab) Herceptin (trastuzumab) Roche Remicade (inflximab), Johnson&Johnson, Merck&Co Mitsubishi Tanabe. 2023 . 57% .
, 2023 . , , , . 2014 .
, , . Omnitrope (somatropin) Sandoz 2004 ., .
Visiongain , , , . , Pfizer, Merck&Co Boehringer Ingelheim, . .
, , .. , .
, , , , .
2012 . . 20 .